There are 4 papers on aging in Mammalian models: none in people yet, 4 reviews.
4 papers study it3 findings
1 new paper in 30 daysSee all 4 papers on Mammalian models
Interventions
2FOXO4-DRI
upcognitive function1downsenescent cell accumulation1
1 study
FOXO4-DRI
upcognitive function1downsenescent cell accumulation1
FOXO4-DRI decreases senescent cell accumulation in M. models.
“In aged mammalian models, administering FOXO4-DRI decreases the accumulation of senescent cells”
Reviewbrain
Naunyn-Schmiedeberg's archives of pharmacology
FOXO4-DRI improves cognitive function in M. models.
“administering FOXO4-DRI decreases the accumulation of senescent cells, restores cerebral blood flow and the integrity of the blood-brain barrier (BBB), reverses hippocampal atrophy, and enhances cognitive function.”
Reviewbrain
Naunyn-Schmiedeberg's archives of pharmacology
Polycaprolactone
upfollicle survival1
1 study
Polycaprolactone
upfollicle survival1
Polycaprolactone improves follicle survival in M. models.
“particularly electrospun poly(ε-caprolactone), offer superior control over architecture, reproducibility and scalability, supporting follicle survival across multiple mammalian models.”
Reviewelectrospun scaffoldovarian follicle
Scaffold-based biomaterials in ovarian tissue engineering
RSC advances
Latest
2 papers in 12 monthsJurnal Indonesia Sosial Sains
Meningeal Lymphatic System in Neurodegenerative Disorders: A Systematic Review
Systematic reviewMechanisms
Naunyn-Schmiedeberg's Archives of Pharmacology
Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline
ReviewSenolytics
Acta Pharmaceutica Sinica B
Trends in intestinal aging: From underlying mechanisms to therapeutic strategies
ReviewGut and microbiome
Human Reproduction Update
Ovarian ageing: the role of mitochondria in oocytes and follicles
ReviewMitochondrion